For more information, please contact us today or request an appointment online
For instance, in October 2022, the government of Canada announced a new framework for diabetes in Canada
If its outside our normal business hours, well call you the next day
Perspectivas de aprovao e disponibilidade no Brasil Atualmente, a retatrutida est em fase 2 de estudos clnicos, e os resultados positivos aumentam as expectativas para sua aprovao pelas autoridades regulatrias, com grandes expectativas para a prxima etapa de ensaios clnicos (a fase 3)
The Ozempic, Semaglutide, and GLP-1 Problem For Employers Since the Food and Drug Administration first approved semaglutide (a type of GLP-1 drug) as an injectable weight loss medication in 2021, the demand for brand name versions like Ozempic and Wegovy has skyrocketed